Peptide Safety
5 articles on Peptide Safety, written by Shotlee and medically reviewed for clinical accuracy.
MHRA Investigates UK Peptide Clinics Over Health Claims
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is investigating peptide clinics for making bold health claims about unregulated therapies. Clinics promote peptides like BPC-157 for injury recovery and MOTS-C for energy, despite scant human evidence. This Guardian-revealed probe highlights risks in the booming peptide market.
6 min read
What Are Peptides? Are They Safe and Backed by Evidence?
Peptides are short amino acid chains hailed by influencers for wellness benefits like injury repair and weight loss, but many lack human evidence. From approved drugs like semaglutide in Wegovy to unregulated options like the 'Wolverine stack' of BPC-157 and TB-500, we examine the science, legality, and risks in the UK.
5 min read
RFK Jr.'s Peptide Push: Risks of Bypassing FDA Trials
Robert F. Kennedy Jr., US health secretary nominee, wants to open sales of restricted injectable peptides, fitting his Make America Healthy Again agenda. While some peptides show promise, the FDA halted 17 in 2023 due to safety risks—without trials, anecdote isn't evidence. This editorial warns against sidelining regulation for wellness hucksters.
4 min read
RFK Jr. Plans to Unban 14 FDA-Banned Peptides, Tells Joe Rogan
RFK Jr. revealed on the Joe Rogan Experience his intent to lift FDA restrictions on 14 banned peptides from compounding pharmacies. This reversal addresses the late 2023 Category 2 list ban amid safety concerns and black market shifts. Patients and wellness advocates await formal decisions in coming weeks.
5 min read
Temu Peptides: Why Buying Them Seems Bad
Silicon Valley's biohacking craze has hit Temu, where peptides are sold for pennies, raising alarms about safety and purity. From BPC-157 vials to questionable GLP-1s, these products bypass rigorous testing. A closer look reveals why this mainstream shift could be disastrous for health.
5 min read